10-Q Filing

Oruka Therapeutics, Inc. CIK: 907654 Q3 2024

Filing Information

Form Type	10-Q
Accession Number	`0001213900-24-097443`
Period End Date	20240930
Filing Date	20241113
Fiscal Year	2024
Fiscal Period	Q3
XBRL Instance	ea0216929-10q_oruka_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 100 Income Statement 56 Cash Flow Statement 76 Stockholders Equity 50

Balance Sheet 100 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$410.88M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$410.88M	USD	Point-in-time
Subscription receivable	`SubscriptionReceivables`	-	USD	Point-in-time
Subscription receivable	`SubscriptionReceivables`	-	USD	Point-in-time
Subscription receivable	`SubscriptionReceivables`	$1.00K	USD	Point-in-time
Subscription receivable	`SubscriptionReceivables`	$1.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.07M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.07M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	-	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$412.95M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$412.95M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$160.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$160.00K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	65.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	65.00M	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	545.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	545.00M	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$938.00K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$938.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$43.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$43.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.20M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.20M	shares	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	35.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	35.00M	shares	Point-in-time
Total assets	`Assets`	$1.00K	USD	Point-in-time
Total assets	`Assets`	$1.00K	USD	Point-in-time
Total assets	`Assets`	$414.09M	USD	Point-in-time
Total assets	`Assets`	$414.09M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	35.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	35.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.20M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.20M	shares	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$2.15M	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$2.15M	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	-	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	-	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	-	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	-	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.71M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.71M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$146.00K	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$146.00K	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.04M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$18.04M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	-	USD	Point-in-time
Operating lease liability, non-current	`OperatingLeaseLiabilityNoncurrent`	$842.00K	USD	Point-in-time
Operating lease liability, non-current	`OperatingLeaseLiabilityNoncurrent`	$842.00K	USD	Point-in-time
Operating lease liability, non-current	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Operating lease liability, non-current	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	-	USD	Point-in-time
Total liabilities	`Liabilities`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$18.88M	USD	Point-in-time
Total liabilities	`Liabilities`	$18.88M	USD	Point-in-time
Commitment and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitment and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitment and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitment and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 and $0.0001 par value as of September 30, 2024 and February 6, 2024, respectively; 545,000,000 and 65,000,000 shares authorized, 34,998,550 and 3,197,975 shares issued and outstanding as of September 30, 2024 and February 6, 2024, respectively	`CommonStockValue`	-	USD	Point-in-time
Common stock, $0.001 and $0.0001 par value as of September 30, 2024 and February 6, 2024, respectively; 545,000,000 and 65,000,000 shares authorized, 34,998,550 and 3,197,975 shares issued and outstanding as of September 30, 2024 and February 6, 2024, respectively	`CommonStockValue`	-	USD	Point-in-time
Common stock, $0.001 and $0.0001 par value as of September 30, 2024 and February 6, 2024, respectively; 545,000,000 and 65,000,000 shares authorized, 34,998,550 and 3,197,975 shares issued and outstanding as of September 30, 2024 and February 6, 2024, respectively	`CommonStockValue`	$35.00K	USD	Point-in-time
Common stock, $0.001 and $0.0001 par value as of September 30, 2024 and February 6, 2024, respectively; 545,000,000 and 65,000,000 shares authorized, 34,998,550 and 3,197,975 shares issued and outstanding as of September 30, 2024 and February 6, 2024, respectively	`CommonStockValue`	$35.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$397.35M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$397.35M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-57.94M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-57.94M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	-	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$342.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$342.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-7.06M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$-7.06M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.00K	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity	`LiabilitiesAndStockholdersEquity`	$1.00K	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity	`LiabilitiesAndStockholdersEquity`	$414.09M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders equity	`LiabilitiesAndStockholdersEquity`	$414.09M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$25.69M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$25.69M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$49.56M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$49.56M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.25M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.25M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.76M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.76M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$29.45M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$29.45M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$57.80M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$57.80M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-57.80M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-57.80M	USD	3 Qtrs
Related party amount	`CostsAndExpensesRelatedParty`	$1.47M	USD	3 Qtrs
Related party amount	`CostsAndExpensesRelatedParty`	$1.47M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-29.45M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-29.45M	USD	1 Quarter
Related party amount	`CostsAndExpensesRelatedParty`	$504.00K	USD	1 Quarter
Related party amount	`CostsAndExpensesRelatedParty`	$504.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.33M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.33M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.33M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.33M	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$1.47M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$1.47M	USD	3 Qtrs
Interest expense	`InterestExpenseNonoperating`	$504.00K	USD	1 Quarter
Interest expense	`InterestExpenseNonoperating`	$504.00K	USD	1 Quarter
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$826.00K	USD	1 Quarter
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$826.00K	USD	1 Quarter
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$-138.00K	USD	3 Qtrs
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$-138.00K	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss and comprehensive loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Net loss and comprehensive loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Net loss per share attributable to stockholders, basic (in Dollars per share)	`EarningsPerShareBasic`	$-6.08	USD	3 Qtrs
Net loss per share attributable to stockholders, basic (in Dollars per share)	`EarningsPerShareBasic`	$-6.08	USD	3 Qtrs
Net loss per share attributable to stockholders, basic (in Dollars per share)	`EarningsPerShareBasic`	$-1.46	USD	1 Quarter
Net loss per share attributable to stockholders, basic (in Dollars per share)	`EarningsPerShareBasic`	$-1.46	USD	1 Quarter
Net loss per share attributable to stockholders, diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-6.08	USD	3 Qtrs
Net loss per share attributable to stockholders, diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-6.08	USD	3 Qtrs
Net loss per share attributable to stockholders, diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-1.46	USD	1 Quarter
Net loss per share attributable to stockholders, diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-1.46	USD	1 Quarter
Weighted-average shares used in computing net loss per share attributable to stockholders, basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	15.01M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable to stockholders, basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	15.01M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable to stockholders, basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.77M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable to stockholders, basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.77M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable to stockholders, diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.77M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable to stockholders, diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.77M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share attributable to stockholders, diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	15.01M	shares	1 Quarter
Weighted-average shares used in computing net loss per share attributable to stockholders, diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	15.01M	shares	1 Quarter

Cash Flow Statement 76 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Depreciation expense	`Depreciation`	$11.00K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$11.00K	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$9.77M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$9.77M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$9.00M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$9.00M	USD	1 Quarter
Non-cash interest expense	`OtherNoncashExpense`	$1.47M	USD	3 Qtrs
Non-cash interest expense	`OtherNoncashExpense`	$1.47M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$65.00K	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseExpense`	$65.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$1.98M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesOther`	$1.98M	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$43.00K	USD	3 Qtrs
Other non-current assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$43.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$1.62M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$1.62M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.65M	USD	3 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$1.65M	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$6.00K	USD	3 Qtrs
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$6.00K	USD	3 Qtrs
Related party accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableRelatedParties`	$6.36M	USD	3 Qtrs
Related party accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableRelatedParties`	$6.36M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-39.02M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-39.02M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$171.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$171.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-171.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-171.00K	USD	3 Qtrs
Proceeds from issuance of Pre-Merger Oruka Series A Preferred Stock, net of issuance costs paid	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$2.93M	USD	3 Qtrs
Proceeds from issuance of Pre-Merger Oruka Series A Preferred Stock, net of issuance costs paid	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$2.93M	USD	3 Qtrs
Proceeds from issuance of Pre-Merger Oruka Series A Preferred Stock, net of issuance costs paid	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$3.00M	USD	Point-in-time
Proceeds from issuance of Pre-Merger Oruka Series A Preferred Stock, net of issuance costs paid	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$3.00M	USD	Point-in-time
Proceeds from issuance of notes payable to related parties, net of issuance costs paid	`ProceedsFromNotesPayable`	$24.98M	USD	3 Qtrs
Proceeds from issuance of notes payable to related parties, net of issuance costs paid	`ProceedsFromNotesPayable`	$24.98M	USD	3 Qtrs
Proceeds from the Pre-Closing Financing, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$228.13M	USD	3 Qtrs
Proceeds from the Pre-Closing Financing, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$228.13M	USD	3 Qtrs
Proceeds from the PIPE Financing, net	`ProceedsFromIssuanceOfPrivatePlacement`	$189.09M	USD	3 Qtrs
Proceeds from the PIPE Financing, net	`ProceedsFromIssuanceOfPrivatePlacement`	$189.09M	USD	3 Qtrs
Cash acquired in connection with the reverse recapitalization	`CashAssumedInConnectionWithTheReverseRecapitalization`	$4.94M	USD	3 Qtrs
Cash acquired in connection with the reverse recapitalization	`CashAssumedInConnectionWithTheReverseRecapitalization`	$4.94M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$450.06M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$450.06M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$410.88M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$410.88M	USD	3 Qtrs
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$410.88M	USD	Point-in-time
Cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$410.88M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$410.88M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$410.88M	USD	Point-in-time
Operating lease liability arising from obtaining operating right-of-use asset	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$982.00K	USD	3 Qtrs
Operating lease liability arising from obtaining operating right-of-use asset	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$982.00K	USD	3 Qtrs
Assets acquired in connection with the reverse recapitalization	`NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1`	$114.00K	USD	3 Qtrs
Assets acquired in connection with the reverse recapitalization	`NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1`	$114.00K	USD	3 Qtrs
Other liabilities assumed in connection with the reverse recapitalization	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$54.00K	USD	3 Qtrs
Other liabilities assumed in connection with the reverse recapitalization	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$54.00K	USD	3 Qtrs
Pre-Closing Financing and reverse recapitalization issuance costs included in accounts payable	`UnpaidPreclosingFinancingAndReverseRecapitalizationIssuanceCostsIncludedInAccountsPayable`	$150.00K	USD	3 Qtrs
Pre-Closing Financing and reverse recapitalization issuance costs included in accounts payable	`UnpaidPreclosingFinancingAndReverseRecapitalizationIssuanceCostsIncludedInAccountsPayable`	$150.00K	USD	3 Qtrs
PIPE Financing issuance costs included in accounts payable	`UnpaidPIPEFinancingIssuanceCostsIncludedInAccountsPayable`	$374.00K	USD	3 Qtrs
PIPE Financing issuance costs included in accounts payable	`UnpaidPIPEFinancingIssuanceCostsIncludedInAccountsPayable`	$374.00K	USD	3 Qtrs
PIPE Financing issuance costs included in accrued expenses and other current liabilities	`UnpaidPIPEFinancingIssuanceCostsIncludedInAccruedExpensesAndOtherCurrentLiabilties`	$6.00K	USD	3 Qtrs
PIPE Financing issuance costs included in accrued expenses and other current liabilities	`UnpaidPIPEFinancingIssuanceCostsIncludedInAccruedExpensesAndOtherCurrentLiabilties`	$6.00K	USD	3 Qtrs
Non-cash accrued interest on convertible note converted to common stock	`NoncashAccruedInterestOnConvertibleNoteConvertedToCommonStock`	$1.47M	USD	3 Qtrs
Non-cash accrued interest on convertible note converted to common stock	`NoncashAccruedInterestOnConvertibleNoteConvertedToCommonStock`	$1.47M	USD	3 Qtrs
Non-cash exchange of Pre-Merger Oruka Series A Preferred Stock for Company Series B Convertible Preferred Stock	`DebtConversionConvertedInstrumentAmount1`	$2.93M	USD	3 Qtrs
Non-cash exchange of Pre-Merger Oruka Series A Preferred Stock for Company Series B Convertible Preferred Stock	`DebtConversionConvertedInstrumentAmount1`	$2.93M	USD	3 Qtrs

Stockholders Equity 50 line items

Line Item	Tag	Value	Unit	Period
Issuance of Series A Convertible Preferred Stock, Net of Issuance Costs	`IssuanceOfSeriesAConvertiblePreferredStockNetOfIssuanceCosts`	$69.00K	USD	1 Quarter
Issuance of Series A Convertible Preferred Stock, Net of Issuance Costs	`IssuanceOfSeriesAConvertiblePreferredStockNetOfIssuanceCosts`	$69.00K	USD	1 Quarter
Balances	`StockholdersEquity`	$342.37M	USD	Point-in-time
Balances	`StockholdersEquity`	$342.37M	USD	Point-in-time
Balances	`StockholdersEquity`	$1.00K	USD	Point-in-time
Balances	`StockholdersEquity`	$1.00K	USD	Point-in-time
Balances	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$-7.06M	USD	Point-in-time
Balances	`StockholdersEquity`	$-7.06M	USD	Point-in-time
Issuance of common stock	`AdjustmentForChangeInCommonStockParValueInConnectionWithTheReverseMerger`	-	USD	1 Quarter
Issuance of common stock	`AdjustmentForChangeInCommonStockParValueInConnectionWithTheReverseMerger`	-	USD	1 Quarter
Issuance of Series A convertible preferred stock, net of issuance costs of $69	`StockIssuedDuringPeriodValueOther`	-	USD	1 Quarter
Issuance of Series A convertible preferred stock, net of issuance costs of $69	`StockIssuedDuringPeriodValueOther`	-	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$321.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$321.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$17.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.75M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.75M	USD	1 Quarter
Exchange of Series A convertible preferred stock for Series B non-voting convertible preferred stock upon the closing of the reverse recapitalization	`ExchangeOfSeriesAConvertiblePreferredStockForSeriesBNonvotingConvertiblePreferredSt`	$2.93M	USD	1 Quarter
Exchange of Series A convertible preferred stock for Series B non-voting convertible preferred stock upon the closing of the reverse recapitalization	`ExchangeOfSeriesAConvertiblePreferredStockForSeriesBNonvotingConvertiblePreferredSt`	$2.93M	USD	1 Quarter
Conversion of convertible notes (including accrued interest) into common stock upon the closing of the reverse recapitalization	`StockIssuedDuringPeriodValueConversionOfUnits`	$26.45M	USD	1 Quarter
Conversion of convertible notes (including accrued interest) into common stock upon the closing of the reverse recapitalization	`StockIssuedDuringPeriodValueConversionOfUnits`	$26.45M	USD	1 Quarter
Issuance of common stock and pre-funded warrants in the Pre-Closing Financing,	`IssuanceOfCommonStockAndPrefundedWarrantsInThePreclosingFinancingNetOfOfferingCos`	$248.46M	USD	1 Quarter
Issuance of common stock and pre-funded warrants in the Pre-Closing Financing,	`IssuanceOfCommonStockAndPrefundedWarrantsInThePreclosingFinancingNetOfOfferingCos`	$248.46M	USD	1 Quarter
Issuance costs of Pre-Closing Financing and reverse recapitalization	`IssuanceCostsOfPreclosingFinancingAndReverseRecapitalization`	$-20.48M	USD	1 Quarter
Issuance costs of Pre-Closing Financing and reverse recapitalization	`IssuanceCostsOfPreclosingFinancingAndReverseRecapitalization`	$-20.48M	USD	1 Quarter
Issuance of common stock to former stockholders of ARCA biopharma, Inc. in connection with the closing of the reverse recapitalization	`IssuanceOfCommonStockToFormerStockholdersOfARCABiopharmaIncInConnectionWithThe`	$5.00M	USD	1 Quarter
Issuance of common stock to former stockholders of ARCA biopharma, Inc. in connection with the closing of the reverse recapitalization	`IssuanceOfCommonStockToFormerStockholdersOfARCABiopharmaIncInConnectionWithThe`	$5.00M	USD	1 Quarter
Issuance of common stock, Series A non-voting convertible preferred stock, and pre-funded warrants in connection with the PIPE Financing	`IssuanceOfCommonStockSeriesANonvotingConvertiblePreferredStockAndPrefundedWarr`	$144.44M	USD	1 Quarter
Issuance of common stock, Series A non-voting convertible preferred stock, and pre-funded warrants in connection with the PIPE Financing	`IssuanceOfCommonStockSeriesANonvotingConvertiblePreferredStockAndPrefundedWarr`	$144.44M	USD	1 Quarter
Issuance cost of PIPE Financing	`IssuanceCostOfPIPEFinancing`	$-8.57M	USD	1 Quarter
Issuance cost of PIPE Financing	`IssuanceCostOfPIPEFinancing`	$-8.57M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.24M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-28.62M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-57.94M	USD	3 Qtrs
Balances	`StockholdersEquity`	$342.37M	USD	Point-in-time
Balances	`StockholdersEquity`	$342.37M	USD	Point-in-time
Balances	`StockholdersEquity`	$1.00K	USD	Point-in-time
Balances	`StockholdersEquity`	$1.00K	USD	Point-in-time
Balances	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$-28.98M	USD	Point-in-time
Balances	`StockholdersEquity`	$-7.06M	USD	Point-in-time
Balances	`StockholdersEquity`	$-7.06M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.